Sign Up to like & get
recommendations!
1
Published in 2019 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2019.01044
Abstract: Acquired resistance inevitably limits the curative effects of epidermal growth factor receptor tyrosine kinase inhibitors (EGFR-TKIs), which represent the classical paradigm of molecular-targeted therapies in non-small-cell lung cancer (NSCLC). How to break such a bottleneck…
read more here.
Keywords:
tki resistance;
resistance;
emt mediated;
mediated acquired ... See more keywords